Phathom Pharmaceuticals Inc Sustainability Reports
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00P5B2S73
2 reports from 2020 to 2024
Company Profile
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
